Literature DB >> 6628510

Pharmacokinetics of aspirin and salicylate in elderly subjects and in patients with alcoholic liver disease.

M S Roberts, R H Rumble, S Wanwimolruk, D Thomas, P M Brooks.   

Abstract

Plasma aspirin, salicylate and salicyluric acid concentrations were monitored in young, elderly and alcoholic subjects after ingestion of a single 1.2 g dose of soluble aspirin. The plasma aspirin, salicylate and unbound salicylate concentration-time profiles varied considerably between individual subjects. Most of the pharmacokinetic parameters derived from these profiles were not significantly different between young subjects, elderly subjects and subjects with alcoholic liver disease. Individual plasma albumin concentrations provided a better index of the unbound plasma salicylate clearances and salicylate plasma protein binding than the age of the subject or the presence of alcoholic liver disease. Highest unbound plasma salicylate concentrations were found in subjects with the lowest plasma albumin concentrations.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6628510     DOI: 10.1007/bf00543800

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  25 in total

1.  Factors affecting drug binding in plasma of elderly patients.

Authors:  S Wallace; B Whiting
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

2.  The effect of ageing on drug absorption from the gut.

Authors:  C M Castleden; C N Volans; K Raymond
Journal:  Age Ageing       Date:  1977-08       Impact factor: 10.668

3.  Curve fitting and modeling in pharmacokinetics and some practical experiences with NONLIN and a new program FUNFIT.

Authors:  P V Pedersen
Journal:  J Pharmacokinet Biopharm       Date:  1977-10

4.  Differential inhibition of prostacyclin production and platelet aggregation by aspirin.

Authors:  G Masotti; G Galanti; L Poggesi; R Abbate; G G Neri Serneri
Journal:  Lancet       Date:  1979-12-08       Impact factor: 79.321

5.  The effects of chronic alcohol ingestion and alcoholic liver disease on drug-protein binding [proceedings].

Authors:  S Boobis; M J Brodie
Journal:  Br J Clin Pharmacol       Date:  1977-10       Impact factor: 4.335

6.  Absorption kinetics of aspirin in man following oral administration of an aqueous solution.

Authors:  M Rowland; S Riegelman; P A Harris; S D Sholkoff
Journal:  J Pharm Sci       Date:  1972-03       Impact factor: 3.534

7.  Simultaneous liquid-chromatographic quantitation of salicylic acid, salicyluric acid, and gentisic acid in urine.

Authors:  B E Cham; F Bochner; D M Imhoff; D Johns; M Rowland
Journal:  Clin Chem       Date:  1980-01       Impact factor: 8.327

8.  Determination of acetylsalicylic acid and salicylic acid in plasma.

Authors:  M Rowland; S Riegelman
Journal:  J Pharm Sci       Date:  1967-06       Impact factor: 3.534

9.  Salicylate metabolite kinetics after several salicylates.

Authors:  F Bochner; G G Graham; B E Cham; D M Imhoff; T M Haavisto
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

10.  Impairment of hepatic drug metabolism in alcoholics.

Authors:  A W Harman; D B Frewin; B G Priestly; C B Alexander
Journal:  Br J Clin Pharmacol       Date:  1979-01       Impact factor: 4.335

View more
  23 in total

Review 1.  Age-related changes in protein binding of drugs: implications for therapy.

Authors:  M K Grandison; F D Boudinot
Journal:  Clin Pharmacokinet       Date:  2000-03       Impact factor: 6.447

Review 2.  Hepatic drug metabolism and aging.

Authors:  C Durnas; C M Loi; B J Cusack
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

3.  Aspirin and salicylic acid decrease c-Myc expression in cancer cells: a potential role in chemoprevention.

Authors:  Guoqiang Ai; Rakesh Dachineni; Pratik Muley; Hemachand Tummala; G Jayarama Bhat
Journal:  Tumour Biol       Date:  2015-08-28

Review 4.  Cardiovascular drug therapy in elderly patients: specific age-related pharmacokinetic, pharmacodynamic and therapeutic considerations.

Authors:  Arduino A Mangoni
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 5.  Guide to drug dosage in hepatic disease.

Authors:  N M Bass; R L Williams
Journal:  Clin Pharmacokinet       Date:  1988-12       Impact factor: 6.447

Review 6.  Plasma protein binding of drugs in the elderly.

Authors:  S M Wallace; R K Verbeeck
Journal:  Clin Pharmacokinet       Date:  1987-01       Impact factor: 6.447

Review 7.  The pharmacokinetics of non-steroidal anti-inflammatory drugs in the elderly.

Authors:  K W Woodhouse; H Wynne
Journal:  Clin Pharmacokinet       Date:  1987-02       Impact factor: 6.447

8.  Plasma protein binding of dipyrone metabolites in man.

Authors:  E Zylber-Katz; L Granit; M Levy
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

9.  Model representation of salicylate pharmacokinetics using unbound plasma salicylate concentrations and metabolite urinary excretion rates following a single oral dose.

Authors:  J Shen; S Wanwimolruk; R D Purves; E G McQueen; M S Roberts
Journal:  J Pharmacokinet Biopharm       Date:  1991-10

Review 10.  The problems and pitfalls of NSAID therapy in the elderly (Part II).

Authors:  A G Johnson; R O Day
Journal:  Drugs Aging       Date:  1991-05       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.